Document is current
Any future updates will be listed below
-
Authors
Nishikubo, Masashi https://orcid.org/0000-0002-6183-8910
Shimomura, Yoshimitsu https://orcid.org/0000-0003-1018-9508
Nakaya, Yosuke
Shinohara, Akihito https://orcid.org/0000-0002-5530-6133
Uchida, Naoyuki https://orcid.org/0000-0001-5952-5926
Takayama, Nobuyuki
Kobayashi, Hikaru
Uehara, Yasufumi
Ishikawa, Jun
Ishiwata, Kazuya
Hiramoto, Nobuhiro
Nakazawa, Hideyuki
Kataoka, Keisuke
Kanda, Junya https://orcid.org/0000-0002-6704-3633
Nagafuji, Koji https://orcid.org/0000-0003-4795-121X
Kozai, Yasuji
Matsuhashi, Yoshiko
Ishimaru, Fumihiko
Kim, Sung-Won
Fukuda, Takahiro
Kanda, Yoshinobu https://orcid.org/0000-0002-4866-9307
Atsuta, Yoshiko https://orcid.org/0000-0003-4404-2870
Kondo, Eisei https://orcid.org/0000-0003-0995-9405
Kako, Shinichi https://orcid.org/0000-0002-2635-3395
- License Information
-
More Information
Article History
Received: 4 July 2024
Revised: 13 September 2024
Accepted: 16 September 2024
First Online: 25 September 2024
Competing interests
: The authors declare no competing interests.
: This study was approved by the Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT) and Institutional Review Board of Kobe City Medical Center General Hospital and was conducted in accordance with the Declaration of Helsinki (approval number: zn230805).
: Written informed consent was obtained from all patients prior to TRUMP2 registration.
